The Clinical Application Value of RAPID Software for Endovascular Treatment Decision of Acute Isolated M2 Occlusion

Zhang J, Yang Z

Department of Neurology, Yongchuan Hospital, Chongqing Medical University, China

^*Correspondance to: Zhao Yang 

 PDF  Full Text Research Article | Open Access

Abstract:

Objective: The aim of this study is to analyze the impact of RAPID software on the efficacy and safety of Endovascular Therapy (EVT) for patients with acute isolated M2 occlusion.
Methods: The patients with acute isolated M2 occlusion received endovascular treatment in our hospital, between January 2020 and April 2021 were retrospectively analyzed. Baseline characteristics and imaging parameters of CTP-RAPID were collected for analysis. The primary outcomes included favorable functional outcomes (modified Rankin Scale ≤ 3) at 90 days, and mortality within 90 days and symptomatic intracerebral hemorrhage were analyzed.
Results: Among the 62 patients enrolled in this study, 48 (40.0%) achieved a good functional outcome (modified Rankin Scale score ≤ 3 at 90 days). In the univariate analysis, Alberta Stroke Program Early CT Score, perfusion deficit volume in time to maximum (Tmax) >6s, and mismatch volume were associated with functional outcomes (all p<0.05). In the multivariate analysis, infarct core (CBF<30%) remained independent outcome predictors (p<0.05).
Conclusion: RAPID software based on CTP represent a promising tool for patients with acute isolated M2 occlusion to make decision and predict prognosis for endovascular treatment.

Keywords:

Computed tomography perfusion; RAPID software; Acute artery occlusion; Endovascular treatment

Cite the Article:

Zhang J, Yang Z. The Clinical Application Value of RAPID Software for Endovascular Treatment Decision of Acute Isolated M2 Occlusion. World J Surg Surgical Res. 2023; 6: 1498..